Ready to play
Ready to play
Sechenov Medical University has introduced a new approach to treating Alzheimer's disease, based on selective plasma absorption of extracellular DNA, a uniquely innovative therapeutic method worldwide. The results confirm that the treatment, which involves three sessions spaced two to three days apart, allowed for the processing of up to 200% of the plasma volume in the blood during each session. After three months of treatment, notable improvements were observed in verbal memory, information processing speed, attention, and certain cognitive functions, reflecting the effectiveness of this new therapy in enhancing the quality of life for Alzheimer's patients.
Notice: This Is an AI-Generated Summary
Comments (0)